Anti-TNF-α (Humicade) Biotinylated Antibody

Anti-TNF-α (Humicade) Biotinylated Antibodyis available at Gentaur for Next week Delivery.

Description: Recombinant monoclonal antibody to TNF-α. Manufactured using recombinant technology with variable regions (i.e. specificity) from the hybridoma CDP 571 (Humicade). The antibody binds specifically to TNF-α, a pro-inflammatory cytokine that stimulates the release of other cytokines e.g. IL-1, IL-6, and GM-CSF as well as secretion of ICAM-1 and VCAM-1 from endothelial cells. It stimulates acute phase responses and acts as a chemoattractant for NK cells and monocytes/macrophages. The antibody reached Phase II clinical trials with Celltech, UCB

Immunogen Sequence:Human TNF-α

Target Alternative Name:BAY 103356, BAY W 3356, CDP 571, DIF, TNFA, TNFSF2, TNLG1F, TNF-alpha, APC1 Protein

Species Reactivities:Human

Tag Line:Recombinant monoclonal antibody to detect the biotinylated TNF-α in human samples

Formulation:In PBS, pH 7.2, 30% glycerol, 0.5% BSA, 0.5 mM EDTA and 0.03% proclin

Purification: Affinity purified using protein A

Application:ELISA

Positive Control:/

Application And Usages:ELISA 0.1 µg - 1 µg/ml

Handling:The antibody solution should be gently mixed before use.